share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director Shulman Douglas H.

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director Shulman Douglas H.

西維斯健康 | 4:持股變動聲明-董事 Shulman Douglas H.
美股SEC公告 ·  11/26 07:12

Moomoo AI 已提取核心訊息

Douglas H. Shulman completed the acquisition of 2,200 shares of CVS Health common stock on 11/21/2024. The transaction was executed at a price of $57.1 per share, resulting in a total transaction value of approximately $125,620. This acquisition was categorized as a grant, award, or other acquisition, and the shares are held directly by Shulman.Following this transaction, Shulman holds a total of 2,200 shares of CVS Health. The transaction was completed on the same day, indicating a swift execution. This acquisition reflects Shulman's direct investment in CVS Health, potentially signaling confidence in the company's future performance.
Douglas H. Shulman completed the acquisition of 2,200 shares of CVS Health common stock on 11/21/2024. The transaction was executed at a price of $57.1 per share, resulting in a total transaction value of approximately $125,620. This acquisition was categorized as a grant, award, or other acquisition, and the shares are held directly by Shulman.Following this transaction, Shulman holds a total of 2,200 shares of CVS Health. The transaction was completed on the same day, indicating a swift execution. This acquisition reflects Shulman's direct investment in CVS Health, potentially signaling confidence in the company's future performance.
道格拉斯·舒爾曼於2024年11月21日完成了對2,200股CVS Health普通股的收購。該交易以每股57.1美元的價格執行,總交易價值約爲125,620美元。此次收購被歸類爲贈款、獎勵或其他收購,股份由舒爾曼直接持有。在這筆交易之後,舒爾曼共持有CVS Health的2,200股股份。該交易於當天完成,表明執行速度很快。此次收購反映了舒爾曼對CVS Health的直接投資,這可能表明人們對公司未來業績充滿信心。
道格拉斯·舒爾曼於2024年11月21日完成了對2,200股CVS Health普通股的收購。該交易以每股57.1美元的價格執行,總交易價值約爲125,620美元。此次收購被歸類爲贈款、獎勵或其他收購,股份由舒爾曼直接持有。在這筆交易之後,舒爾曼共持有CVS Health的2,200股股份。該交易於當天完成,表明執行速度很快。此次收購反映了舒爾曼對CVS Health的直接投資,這可能表明人們對公司未來業績充滿信心。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息